Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -819.34% is 408% below its 4-year average of -161.37%, near the low end of its 4-year range (-819.34%–-0.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 70.13% below its 12-month average of -481.60%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -819.34%.
RETURN ON EQUITY (ROE)
-819.34%
RETURN ON EQUITY (ROE) AVG TTM
-481.60%
RETURN ON EQUITY (ROE) AVG 3Y
-262.81%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-70.13%
CURRENT VS 3Y AVG
-211.76%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-1850.36%
vs the sector median at left
QT Imaging Holdings, Inc.
Market Cap
$35.52M
Return on Equity (ROE)
-819.34%
TTM Avg
-481.60%
3Y Avg
-262.81%
5Y Avg
N/A
Market Cap
$35.76M
Return on Equity (ROE)
-161.63%
TTM Avg
-60.21%
3Y Avg
-26.37%
5Y Avg
-20.13%
Market Cap
$35.84M
Return on Equity (ROE)
-160.05%
TTM Avg
-184.57%
3Y Avg
-168.71%
5Y Avg
-141.15%
Market Cap
$35.84M
Return on Equity (ROE)
-476.77%
TTM Avg
-979.99%
3Y Avg
-646.46%
5Y Avg
-421.61%
Market Cap
$34.97M
Return on Equity (ROE)
-154.06%
TTM Avg
-1.75%
3Y Avg
68.54%
5Y Avg
60.27%
Market Cap
$36.21M
Return on Equity (ROE)
N/A
TTM Avg
333.35%
3Y Avg
376.86%
5Y Avg
270.78%
Market Cap
$34.35M
Return on Equity (ROE)
329.02%
TTM Avg
154.76%
3Y Avg
265.18%
5Y Avg
128.71%
Market Cap
$33.63M
Return on Equity (ROE)
N/A
TTM Avg
105.22%
3Y Avg
53.02%
5Y Avg
47.52%
Market Cap
$33.61M
Return on Equity (ROE)
-44.50%
TTM Avg
-16.33%
3Y Avg
-36.34%
5Y Avg
-33.52%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $35.52M | -819.34% | -481.60% | -262.81% | N/A |
| DocGo Inc. (DCGO)vs › | $35.76M | -161.63% | -60.21% | -26.37% | -20.13% |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | -160.05% | -184.57% | -168.71% | -141.15% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | -476.77% | -979.99% | -646.46% | -421.61% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -154.06% | -1.75% | 68.54% | 60.27% |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | N/A | 333.35% | 376.86% | 270.78% |
| Elutia Inc (ELUT)vs › | $34.35M | 329.02% | 154.76% | 265.18% | 128.71% |
| Scilex Holding Company (SCLX)vs › | $33.63M | N/A | 105.22% | 53.02% | 47.52% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | -44.50% | -16.33% | -36.34% | -33.52% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | -238.24% | 203.84% | 55.01% | 16.87% |
ROE
-819.3%
ROA
-60.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -819.34% |
| 2026-03-31 | -298.34% |
| 2025-12-31 | -327.12% |
| 2023-12-31 | -56.96% |
| 2023-09-30 | -52.19% |
| 2023-06-30 | -22.90% |
| 2023-03-31 | -18.55% |
| 2022-12-31 | -9.73% |
| 2022-09-30 | -7.60% |
| 2022-06-30 | -0.93% |
